Clinical Trials Logo

Clinical Trial Summary

Many drugs used during anesthesia can reduce alertness and therefore present potential risks when driving a vehicle (risk of accident). Some scientific societies recommend not driving for 12 to 24 hours after sedation or general anesthesia. However, there are conflicting data in the literature showing that general anesthesia in healthy volunteers does not impair driving ability as early as 2 hours after the end of anesthesia. This need not to drive requires the outpatient to have an escort. Unfortunately, some patients find it difficult to benefit from an adult escort, which can lead to last minute cancellations, absences or the need for a classic overnight hospital stay. The main objective of the study is to compare with a simulator the driving performances of patients who have benefited from deep sedation for an outpatient endoscopic digestive procedure when they have met the discharge criteria to the performances of their escorts in order to determine if the conditions are as safe to let them drive home.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04948385
Study type Interventional
Source University of Liege
Contact
Status Completed
Phase Phase 4
Start date February 6, 2019
Completion date May 6, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06059677 - Cannabis Consumption and Driving Impairment Assessment on a Closed Course Phase 2
Enrolling by invitation NCT05537116 - Evaluation of an Interactive Mobile Phone-Based Brief Intervention to Reduce Substance-Impaired Driving N/A
Completed NCT03169855 - Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability
Recruiting NCT06111989 - Fitness to Drive Among Stroke Patients
Completed NCT04587609 - Reducing Cell Phone Use While Driving Among High Risk UBI Auto Policy Holders N/A
Completed NCT03656029 - Dose-response of Cannabis and Driving Phase 2
Completed NCT04330196 - Effect of Postprandial Hyperinsulinaemic Hypoglycaemia on Driving Performance. N/A
Completed NCT03353922 - Driving Simulation to Assess Non-Sedative Effects of Tolperisone Phase 1
Completed NCT03335735 - Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving N/A
Not yet recruiting NCT05703360 - Effectiveness of AV-stimulation in Immersive VR to Improve Visual Perception and Driving Performance N/A
Active, not recruiting NCT03581058 - Neural Correlates of Driving and Cannabis Phase 1
Withdrawn NCT05273658 - Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests Phase 1/Phase 2
Completed NCT04648735 - Driving Evaluation and Fitness for Persons With Cognitive Impairments N/A
Completed NCT03195608 - Using Advanced Driver Assistance Systems (ADAS) as an Intervention Strategy for Drivers With Parkinson's Disease N/A